Telo Genomics Corp
Research Telo Genomics Corp (3D0A) on Bullrun: market cap EUR 2.01M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3D0A
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 2.01M
- Financial periodQ4 2025
- Net income-EUR 526.62K
- Free cash flow-EUR 436.40K
Valuation Snapshot
latest market cap is EUR 2.01M.
About Telo Genomics Corp
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments.
Frequently asked questions
What is Telo Genomics Corp's market cap?
Telo Genomics Corp's market capitalization is EUR 2.01M.
What does Telo Genomics Corp do?
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada.